Related Experiment Videos
Human connexin 37 is polymorphic but not mutated in tumours
V Krutovskikh1, N Mironov, H Yamasaki
1Unit of Multistage Carcinogenesis, International Agency for Research on Cancer, Lyon, France.
Carcinogenesis
|August 1, 1996
Summary
Researchers investigated connexin 37 (Cx37) gene mutations in human tumors. They discovered a common polymorphism, not a tumor-specific mutation, in the Cx37 gene within the human population.
Area of Science:
- Molecular biology
- Genetics
- Cancer research
Background:
- Connexins are proteins crucial for gap junctional intercellular communication (GJIC).
- Disruption of GJIC is a common feature in tumor development.
- The connexin 37 (Cx37) gene is expressed in lung and breast tissues.
Purpose of the Study:
- To investigate potential mutations in the connexin 37 (Cx37) gene in human tumors.
- To determine if observed genetic variations are tumor-specific or population polymorphisms.
Main Methods:
- Analysis of DNA from eight lung adenocarcinomas and 18 breast carcinomas.
- Sequencing of the Cx37 gene to identify base changes.
- Screening of normal DNA from patients and healthy donors to assess polymorphism.
Main Results:
- A specific base change (GTA-->ATA) at codon 130 of the Cx37 gene was identified in some lung and breast tumors.
- This base change, resulting in a valine to isoleucine conversion, was also found in normal DNA from the same patients and in healthy donors.
- The prevalence of this variation in both tumor and normal tissues indicates it is a common polymorphism.
Conclusions:
- The identified base change in the connexin 37 gene represents a common human polymorphism, not a tumor-specific mutation.
- This finding is the first documented instance of polymorphism within the connexin gene family.
- The study highlights the importance of distinguishing somatic mutations from germline polymorphisms in cancer research.